Related Experiment Video
Updated: Jul 14, 2025

07:50
Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
Published on: July 16, 2012
14.3K
High-Content Image-Based Screening and Deep Learning for the Detection of Anti-Inflammatory Drug Leads.
Tannia A Lau1, Elmar Mair2, Beverley M Rabbitts1
1Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA 95064, USA.
Chembiochem : a European Journal of Chemical Biology
|October 10, 2023
Summary
We developed an AI-powered image analysis method to screen compounds for anti-inflammatory potential. This approach identified novel drug leads by analyzing cellular responses to lipopolysaccharide (LPS) stimulation in macrophages.
Area of Science:
- Immunology
- Pharmacology
- Computational Biology
Background:
- The innate immune response, particularly macrophage activation by lipopolysaccharide (LPS), is a key target for anti-inflammatory drug discovery.
- Identifying novel compounds that modulate this response requires efficient screening methods.
Purpose of the Study:
- To develop and validate a high-content, image-based screening platform for identifying novel anti-inflammatory compounds.
- To leverage deep learning for analyzing cellular morphology changes induced by LPS stimulation.
Main Methods:
- A high-content image-based screen using murine macrophages (RAW264.7) stimulated with LPS.
- Development of a deep neural network classifier trained on fluorescence microscopy images to detect LPS-induced phenotypes.
- Validation of top hits using linear classifiers and a multiplexed cytokine secretion assay.
Main Results:
- Screened 2,259 bioactive compounds, identifying 12 validated hits that modulated cytokine expression.
- Seven hits were identified as allosteric inhibitors of mitogen-activated protein kinase kinase (MEK1/2).
- The deep learning model effectively distinguished between unstimulated and LPS-stimulated macrophages.
Conclusions:
- The developed deep learning morphological assay is effective in identifying compounds that modulate the innate immune response to LPS.
- This platform shows promise for accelerating the discovery of new anti-inflammatory drug leads.

